CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization: CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 31-1667995)
Tax period: 2011-01-01 to 2011-12-31
Filed: 2012-08-20
IRS object ID: 201222339349300517
Schema version: 2011v1.2
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Timestamp	2012-08-20T13:19:51-05:00	Timestamp
Tax Period End Date	2011-12-31	TaxPeriodEndDate

Preparer Firm PreparerFirm

Field	Value	IRS element (for citing)
EIN	521855942	EIN

Preparer Firm Business Name PreparerFirmBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	TATE AND TRYON	BusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

Field	Value	IRS element (for citing)
Address Line1	2021 L STREET NW SUITE 400	AddressLine1
City	WASHINGTON	City
State	DC	State
ZIP Code	20036	ZIPCode

Field	Value	IRS element (for citing)
Return Type	990	ReturnType
Tax Period Begin Date	2011-01-01	TaxPeriodBeginDate

Filer Filer

Field	Value	IRS element (for citing)
EIN	311667995	EIN

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER FOUNDATION OF THE	BusinessNameLine1
Business Name Line2	AMERICAN SOCIETY OF CLINICAL ONCOLOGY	BusinessNameLine2

Field	Value	IRS element (for citing)
Name Control	CONQ	NameControl
Phone	5714831700	Phone

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Officer Officer

Field	Value	IRS element (for citing)
Name	PAUL AINES	Name
Title	CFO	Title
Phone	5714831300	Phone
Date Signed	2012-08-20	DateSigned
Authorize Third Party	1	AuthorizeThirdParty

Preparer Preparer

Field	Value	IRS element (for citing)
Name	DEBORAH G KOSNETT	Name
PTIN	P00290720	PTIN
Phone	2022932200	Phone

Field	Value	IRS element (for citing)
Tax Year	2011	TaxYear
Build TS	2016-02-24 21:20:13Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Name Of Principal Officer Person	ALLEN LICHTER MD	NameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	38187636	GrossReceipts
Group Return For Affiliates	0	GroupReturnForAffiliates
Organization501c3	X	Organization501c3
Web Site	WWW.CONQUERCANCERFOUNDATION.ORG	WebSite
Type Of Organization Corporation	X	TypeOfOrganizationCorporation
Year Formation	1999	YearFormation
State Legal Domicile	VA	StateLegalDomicile
Activity Or Mission Description	CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) IS THE PHILANTHROPIC ARM OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO). CCF'S FUNDING OF BREAKTHROUGH RESEARCH, PATIENT INFORMATION, PROFESSIONAL EDUCATION, AND QUALITY IMPROVEMENT PROGRAMS IN CANCER CARE GIVES PATIENTS AND CAREGIVERS POWERFUL RESOURCES TO ADDRESS THE DISEASE. THROUGH THESE EFFORTS, CCF IMPROVES THE LIVES OF THOSE IMPACTED BY CANCER.	ActivityOrMissionDescription
Nbr Voting Members Governing Body	12	NbrVotingMembersGoverningBody
Nbr Independent Voting Members	11	NbrIndependentVotingMembers
Total Nbr Employees	0	TotalNbrEmployees
Total Nbr Volunteers	116	TotalNbrVolunteers
Total Gross UBI	0	TotalGrossUBI
Net Unrelated Business Txbl Income	0	NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year	24400007	ContributionsGrantsPriorYear
Contributions Grants Current Year	23070515	ContributionsGrantsCurrentYear
Program Service Revenue Prior Year	0	ProgramServiceRevenuePriorYear
Program Service Revenue CY	0	ProgramServiceRevenueCY
Investment Income Prior Year	265673	InvestmentIncomePriorYear
Investment Income Current Year	902480	InvestmentIncomeCurrentYear
Other Revenue Prior Year	0	OtherRevenuePriorYear
Other Revenue Current Year	0	OtherRevenueCurrentYear
Total Revenue Prior Year	24665680	TotalRevenuePriorYear
Total Revenue Current Year	23972995	TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year	20649143	GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY	16237145	GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year	0	BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY	0	BenefitsPaidToMembersCY
Salaries Etc Prior Year	0	SalariesEtcPriorYear
Salaries Etc Current Year	0	SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year	199150	TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY	534850	TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year	2059964	TotalFundrsngExpCurrentYear
Other Expense Prior Year	3843443	OtherExpensePriorYear
Other Expenses Current Year	3999492	OtherExpensesCurrentYear
Total Expenses Prior Year	24691736	TotalExpensesPriorYear
Total Expenses Current Year	20771487	TotalExpensesCurrentYear
Revenues Less Expenses Prior Year	-26056	RevenuesLessExpensesPriorYear
Revenues Less Expenses CY	3201508	RevenuesLessExpensesCY
Total Assets BOY	36185072	TotalAssetsBOY
Total Assets EOY	36980488	TotalAssetsEOY
Total Liabilities BOY	9750810	TotalLiabilitiesBOY
Total Liabilities EOY	8631006	TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY	26434262	NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY	28349482	NetAssetsOrFundBalancesEOY
Info In Schedule O Part III	X	InfoInScheduleOPartIII
Mission Description	THE MISSION STATEMENT FOR CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) IS: CONQUERING CANCER WORLDWIDE BY FUNDING BREAKTHROUGH RESEARCH AND SHARING CUTTING-EDGE KNOWLEDGE. CCF'S VISION IS A WORLD FREE FROM THE FEAR OF CANCER.	MissionDescription
Significant New Program Services	0	SignificantNewProgramServices
Significant Change	0	SignificantChange
Expense	8446472	Expense
Grants	7961750	Grants
Description	PROFESSIONAL EDUCATION - THE FIELD OF ONCOLOGY IS A DYNAMIC ARENA WHERE DEVELOPMENTS AND DISCOVERIES OCCUR NEARLY EVERY DAY. STAYING ABREAST OF THESE DEVELOPMENTS IS CRITICAL IN ALLOWING CANCER PHYSICIANS AND OTHER HEALTHCARE PROFESSIONALS TO PROVIDE EACH PERSON WITH CANCER THE BEST TREATMENT OPTIONS AVAILABLE. THROUGH ITS SUPPORT OF THE EDUCATIONAL AND SCIENTIFIC PROGRAMS OF ITS NON-PROFIT, CHARITABLE, RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE FOUNDATION PROVIDES EDUCATIONAL AND SCIENTIFIC OPPORTUNITIES FOR ONCOLOGISTS AND OTHER HEALTHCARE PROFESSIONALS FROM AROUND THE GLOBE. TO ENSURE THAT THE HIGHEST-QUALITY CANCER EDUCATION CONTINUES TO BE AVAILABLE TO DOCTORS IN AN INDEPENDENT AND UNBIASED FORUM, FUNDS FROM CCF ARE USED TO SUPPORT ASCO'S COMPREHENSIVE SCIENTIFIC AND EDUCATIONAL PROGRAMS THAT PROVIDE THE LATEST DATA TO CANCER DOCTORS AND OTHER HEALTHCARE PROFESSIONALS WORLDWIDE THROUGH BOTH LIVE MEETINGS AND PRINT AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC MEETINGS SUPPORTED BY CCF AND PRESENTED TO THE PUBLIC IN 2011 INCLUDE: * THE 2011 ANNUAL MEETING FEATURED NEARLY 250 EDUCATIONAL AND SCIENTIFIC SESSIONS. OVER 4,000 ABSTRACTS WERE PRESENTED OR PUBLISHED. OVER 1,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY. THE ASCO ANNUAL MEETING IS THE WORLD'S PREMIER SCIENTIFIC AND EDUCATIONAL EVENT IN THE ONCOLOGY COMMUNITY. IT IS STRUCTURED AS A SERIES OF EDUCATIONAL AND SCIENTIFIC SESSIONS IN DISEASE-SPECIFIC OR ONCOLOGY-RELATED TOPICS. * GI SYMPOSIUM - THE ANNUAL GASTROINTESTINAL CANCERS SYMPOSIUM IS THE PREMIERE MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING OFFERING THE MOST UP-TO-DATE STRATEGIES IN PREVENTION, SCREENING, AND TREATMENT OF GASTROINTESTINAL CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF SURGICAL ONCOLOGY. * GU SYMPOSIUM - THE ANNUAL GENITOURINARY CANCERS SYMPOSIUM IS THE PREEMINENT GENITOURINARY CANCER SCIENTIFIC AND EDUCATIONAL MEETING PROVIDING THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF UROLOGIC ONCOLOGY. * BREAST CANCER SYMPOSIUM - THE ANNUAL BREAST CANCER SYMPOSIUM FEATURES PRESENTATIONS ON THE LATEST MULTIDISCIPLINARY RESEARCH FROM SELECTED, THEME-BASED TRANSLATIONAL AND CLINICAL ABSTRACTS, AS WELL AS RELATED EDUCATIONAL SESSIONS. THE SYMPOSIUM PROVIDES AN OPPORTUNITY FOR EDUCATION REGARDING THE MOST CUTTING-EDGE SCIENTIFIC RESEARCH IN BREAST CANCER TODAY. THE MEETING IS JOINTLY DEVELOPED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY OF BREAST DISEASE, THE AMERICAN SOCIETY OF BREAST SURGEONS, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, THE NATIONAL CONSORTIUM OF BREAST CENTERS, INC., AND THE SOCIETY OF SURGICAL ONCOLOGY.* BEST OF ASCO HELD IN SEATTLE, WA AND MIAMI, FL - THE BEST OF ASCO MEETINGS ARE DESIGNED AS A WORKSHOP, FOCUSED ON THE PRESENTATION AND DISCUSSION OF 50 OF THE TOP ASCO ANNUAL MEETING ABSTRACTS. A PANEL OF ASCO EXPERTS SELECTS ABSTRACTS THAT HIGHLIGHT THE IMPORTANT SCIENTIFIC INFORMATION TO CREATE THE BEST OF ASCO MEETING PROGRAM. * ASCO/AACR METHODS WORKSHOP - THIS INTENSIVE ANNUAL WORKSHOP, IN COLLABORATION WITH THE AMERICAN ASSOCIATION OF CANCER RESEARCH, BRINGS TOGETHER CLINICAL FELLOWS AND JUNIOR FACULTY CLINICAL RESEARCHERS IN ALL ONCOLOGY SUBSPECIALTIES TO LEARN ABOUT THE ESSENTIALS OF EFFECTIVE CLINICAL TRIAL DESIGNS OF THERAPEUTIC INTERVENTIONS IN THE TREATMENT OF CANCER.HIGHLIGHTS OF PRINT AND ELECTRONIC PROFESSIONAL EDUCATION MATERIALS SUPPORTED BY CCF AND AVAILABLE TO THE PUBLIC IN 2011 INCLUDE: PROCEEDINGS - THE PROCEEDINGS PUBLICATIONS FOR THE ASCO ANNUAL MEETING AND SELECT ASCO THEMATIC SYMPOSIA CONTAIN ALL THE ABSTRACTS SELECTED FOR PRESENTATION AT THE LIVE EDUCATIONAL MEETING AND ALLOWS THOSE NOT ABLE TO ATTEND ACCESS TO THE GROUND-BREAKING ABSTRACTS THAT WERE PRESENTED.EDUCATIONAL BOOKS -THE ANNUAL MEETING EDUCATIONAL BOOK IS THE COMPREHENSIVE RESOURCE FOR EDUCATION SESSION MATERIALS, ALLOWING THE ENTIRE ONCOLOGY COMMUNITY TO BENEFIT FROM DISCUSSIONS OF CRITICAL RESEARCH UPDATES IN A POINT-OF-CARE CONTEXT. MANUSCRIPTS DISCUSS THE CURRENT STANDARDS OF CARE AND EXISTING TECHNOLOGIES BUT ALSO LOOK TOWARD THE FUTURE, DISCUSSING RESEARCH IMPROVEMENTS AND TRENDS AND TREATMENTS STILL ON THE HORIZON. ABSTRACTS ON ASCO.ORG - ABSTRACTS ON ASCO.ORG PROVIDE THE RESULTS OF THE LATEST CLINICAL CANCER RESEARCH TO HEALTHCARE PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE. THE ABSTRACTS ON ASCO.ORG COMPRISE ASCO'S COMPREHENSIVE ONLINE DATABASE OF ONCOLOGY-RELATED RESEARCH ABSTRACTS FROM ASCO SCIENTIFIC AND EDUCATIONAL MEETINGS DATING BACK TO 1995.VIRTUAL MEETINGS ON ASCO.ORG - THE VIRTUAL MEETINGS WEBSITE PROVIDES THE RESULTS OF THE LATEST CLINICAL CANCER RESEARCH TO HEALTHCARE PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE. EACH SESSION INCLUDED ON THE VIRTUAL MEETINGS HAS ITS OWN OBJECTIVES. THE VIRTUAL MEETINGS ON ASCO.ORG USE THE LATEST TECHNOLOGY TO DELIVER OVER 25,000 ORAL PRESENTATIONS, ABSTRACTS, AND POSTERS FROM ASCO SCIENTIFIC AND EDUCATIONAL MEETINGS DATING BACK TO 1999 - THE MOST COMPREHENSIVE COLLECTION OF ONCOLOGY-RELATED MULTIMEDIA LECTURES AVAILABLE ON THE WEB.ONLINE PORTALS - ASCO WEBSITES PROVIDE FAST, EASY NAVIGATION AND ADVANCED SEARCH CAPABILITIES. THE ASCO ONLINE PLATFORM HOSTS DISEASE-SPECIFIC PORTAL SITES. THESE "CANCER PORTALS" ARE ORGANIZED THEMATICALLY TO ALLOW SITE USERS TO EASILY ACCESS THE WEALTH OF DISEASE-SPECIFIC INFORMATION AVAILABLE. ASCO UNIVERSITY - ASCO UNIVERSITY IS AN ONLINE EDUCATIONAL PLATFORM THAT IS A RESOURCE FOR EDUCATION AND INFORMATION FOR ONCOLOGISTS. ASCO UNIVERSITY SERVES AS THE EDUCATIONAL HOME AND SOURCE FOR LIFE-LONG LEARNING ACTIVITIES FOR PRACTICING ONCOLOGISTS AND THE NEXT GENERATION OF FELLOWS AND RESIDENTS. THE ACTIVITIES ON ASCO UNIVERSITY INCORPORATE FLEXIBLE, ROBUST CURRICULA WITH COLLATERAL PRODUCTS THAT TRANSLATE KEY ADULT LEARNING PRINCIPLES INTO INTERACTIVE EDUCATIONAL EXPERIENCES.	Description

Activity2 Activity2

Field	Value	IRS element (for citing)
Expense	8340286	Expense
Grants	7098612	Grants
Description	RESEARCH - IN THIS AGE OF SCIENTIFIC PROMISE, FEDERAL FUNDS FOR CANCER RESEARCH ARE DECLINING. FULFILLING THE PROMISE OF TODAY'S ADVANCES RELIES ON FUNDING FOR RESEARCH PROJECTS AND SUPPORT FOR INVESTIGATORS WHO WISH TO PURSUE A CAREER IN CLINICAL AND TRANSLATIONAL CANCER RESEARCH. WITHOUT CONTINUED, WELL-TARGETED RESEARCH, THERE WOULD BE NO MEANINGFUL PROGRESS. AS A CHARITABLE ORGANIZATION, THE FOUNDATION SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. EACH YEAR, CCF FUNDS AND AWARDS MULTIPLE RESEARCH GRANTS DESIGNED TO HELP ATTRACT AND RETAIN THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TO SUPPORT THEIR EFFORTS. HIGHLIGHTS OF 2011 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE:IMPROVING CANCER CARE GRANT FUNDED BY SUSAN G. KOMEN FOR THE CURE(R) (ICCG) - $1.35 MILLION PROVIDED A GRANT TO ADDRESS IMPORTANT ISSUES REGARDING ACCESS TO HEALTHCARE, QUALITY OF CARE, AND DELIVERY OF CARE, WITH GENERAL APPLICABILITY TO BREAST CANCER. THE GOAL OF THIS PROGRAM WAS TO ENCOURAGE MULTI-DISCIPLINARY RESEARCH THAT WILL HAVE A MAJOR IMPACT ON CANCER CARE, WITH GENERAL APPLICABILITY IN THE BREAST CANCER ARENA.ADVANCED CLINICAL RESEARCH AWARD (ACRA)-$450,000 IN FUNDING PROVIDED ONE (1) THREE-YEAR AWARD INTENDED TO FUND INVESTIGATORS WHO ARE COMMITTED TO A CLINICAL CANCER STUDY AND WHO WISH TO CONDUCT ORIGINAL RESEARCH CURRENTLY NOT FUNDED. TRANSLATIONAL RESEARCH PROFESSORSHIP AWARD (TRP)-$300,000 IN FUNDING PROVIDED A THREE-YEAR AWARD DESIGNED TO PROVIDE FLEXIBLE FUNDING TO AN OUTSTANDING RESEARCHER WHO HAS MADE, AND IS CONTINUING TO MAKE, SIGNIFICANT CONTRIBUTIONS THAT HAVE CHANGED THE DIRECTION OF CANCER RESEARCH, AND WHO PROVIDES MENTORSHIP TO FUTURE TRANSLATIONAL RESEARCHERS. CAREER DEVELOPMENT AWARD (CDA)- $2,000,000 IN FUNDING PROVIDED TEN (10)THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENT AND ARE ESTABLISHING AN INDEPENDENT CLINICAL CANCER RESEARCH PROGRAM. YOUNG INVESTIGATOR AWARD (YIA)-$2,700,000 IN FUNDING PROVIDED FIFTY-FOUR (54)ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE) - $230,000 IN FUNDING PROVIDED TWO (2) ONE-YEAR FELLOWSHIPS TO AN EARLY-CAREER ONCOLOGIST IN A DEVELOPING COUNTRY THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION.GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP -$50,000 IN FUNDING PROVIDED A ONE-YEAR FELLOWSHIP THAT ENABLES AN EARLY-CAREER INVESTIGATOR TO UNDERTAKE A BREAST CANCER PROJECT UNDER THE MENTORSHIP OF THE GIANNI BONADONNA BREAST AWARD RECIPIENTCLINICAL TRIALS PARTICIPATION AWARD (CTPA)-$12,000 IN FUNDING PROVIDED A PROGRAM THAT PUBLICLY HONORS HIGH-QUALITY, COMMUNITY-BASED ONCOLOGY PRACTICES AND INSTITUTIONS THAT ACTIVELY PARTICIPATE IN CLINICAL TRIALS RESEARCH. THIS PROGRAM IS DESIGNED TO ENCOURAGE ONCOLOGY PRACTICES THAT CURRENTLY PARTICIPATE IN CLINICAL TRIALS TO INCREASE THEIR ACCRUAL RATES IN ORDER TO SUPPORT CANCER RESEARCH AND ADVANCES. COMMUNITY ONCOLOGY RESEARCH GRANTS (CORG) - $90,000 IN FUNDING PROVIDED THREE ONE-YEAR GRANTS TO COMMUNITY-BASED PRACTICES TO SUPPORT THEIR EFFORTS TO ENHANCE THEIR CLINICAL TRIALS PROGRAM. MERIT AWARDS- $223,000 PROVIDED FUNDING FOR THE BRADLEY STUART BELLER MERIT AWARD ALONG WITH 172 MERIT AWARDS WHICH RECOGNIZE CLINICAL RESEARCH CONDUCTED BY YOUNG SCIENTISTS AND PROVIDE FELLOWS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS AND DISEASE-SPECIFIC SYMPOSIA. A SELECT NUMBER OF MERIT AWARDS WERE GIVEN OUT TO RECOGNIZE OUTSTANDING RESEARCH REFLECTED IN ABSTRACTS SUBMITTED FOR PRESENTATION AT DIFFERENT ASCO SCIENTIFIC MEETINGS.ONCOLOGY TRAINEE TRAVEL AWARDS- $244,000 IN FUNDING PROVIDED FOR 103 AWARDS TO SUPPORT CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS AND ENCOURAGE A FOCUS ON CLINICAL ONCOLOGY.STATE AFFILIATE GRANT PROGRAM- ASCO CREATED THE STATE AFFILIATE GRANT PROGRAM TO SUPPORT ACTIVITIES AND PROGRAMS OF ITS SEPARATELY INCORPORATED STATE/REGIONAL AFFILIATES. IN 2011, $50,000 IN FUNDING PROVIDED FIVE AFFILIATES GRANTS TO ENGAGE IN PROJECTS.CCF ALSO RAISED FUNDS FOR A NUMBER OF AWARDS PROVIDED BY ASCO IN ORDER TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS THAT HAVE MADE SIGNIFICANT CONTRIBUTIONS TO ASCO, THE PRACTICE OF CLINICAL ONCOLOGY, AND CANCER PATIENTS. HIGHLIGHTS OF AWARDS SUPPORTED BY THE FOUNDATION IN 2011 INCLUDED:GIANNI BONADONNA BREAST CANCER AWARD AND LECTURE- THIS AWARD RECOGNIZED AN ACTIVE CLINICAL OR TRANSLATIONAL RESEARCHER WITH A DISTINGUISHED RECORD OF ACCOMPLISHMENTS IN ADVANCING THE FIELD OF BREAST CANCER AS WELL AS EXCEPTIONAL MENTORING ABILITIES. THE AWARD WINNER GAVE A LECTURE DURING THE BREAST CANCER SYMPOSIUM.BJ KENNEDY AWARD AND LECTURE- THIS AWARD RECOGNIZED A GERIATRIC ONCOLOGIST WHO HAS DEMONSTRATED OUTSTANDING LEADERSHIP AND ACHIEVEMENT IN THE FIELD OF GERIATRIC ONCOLOGY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.AMERICAN CANCER SOCIETY AWARD AND LECTURE - THIS AWARD RECOGNIZED AN ONCOLOGIST THAT HAS MADE A SIGNIFICANT CONTRIBUTION TO CANCER PREVENTION AND CONTROL RESEARCH OR PRACTICE. THE AWARD IS JOINTLY SUPPORTED BY THE AMERICAN CANCER SOCIETY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THIS AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE CONTINUING MEDICAL EDUCATION, AND ASSIST IN CAREER DEVELOPMENT TO ENHANCE THE QUALITY OF CANCER CARE WORLDWIDE.	Description

Activity3 Activity3

Field	Value	IRS element (for citing)
Expense	607431	Expense
Grants	606331	Grants
Description	QUALITY AND ACCESS TO CARE-ADVANCES IN CANCER CARE ARE OCCURRING MORE AND MORE FREQUENTLY. YET, THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH-QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CONQUER CANCER FOUNDATION IS AWARE OF THE DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE, AND THOSE WITHOUT. STATE/REGIONAL AFFILIATE PROGRAM-THE ASCO STATE/REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ADDRESS THE CHALLENGES IN THE PRACTICE OF ONCOLOGISTS ON THE LOCAL LEVEL IN THE EVER-CHANGING HEALTHCARE ENVIRONMENT. THE PROGRAM INCLUDES 48 STATE OR REGIONAL ONCOLOGY GROUPS RECEIVE EXPERTISE AND GUIDANCE ON WAYS TO STRENGTHEN THEIR ORGANIZATIONS, ENHANCE THEIR EDUCATIONAL ACTIVITIES, AND PROVIDE SUPPORT FOR THEIR MEMBERS TO IMPROVE THE QUALITY OF CANCER CARE. DIVERSITY IN ONCOLOGY INITIATIVE-THE CONQUER CANCER FOUNDATION GRANTS AND AWARDS PROGRAM OFFERS OR PROVIDES FUNDING FOR DIFFERENT TYPES OF AWARD OPPORTUNITIES FOR ONCOLOGY FELLOWS, CLINICAL PRACTICES, AND INTERNATIONAL RESEARCHERS. ONE OF THE PROGRAMS OFFERED THROUGH CCF IS THE ASCO DIVERSITY IN ONCOLOGY INITIATIVE, FUNDED BY SUSAN G. KOMEN FOR THE CURE(R). THE ASCO DIVERSITY IN ONCOLOGY INITIATIVE WAS STRUCTURED TO FACILITATE THE RECRUITMENT AND RETENTION OF INDIVIDUALS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE TO CANCER CAREERS, WITH PARTICULAR ATTENTION TO THE DEVELOPMENT OF CLINICAL PRACTITIONERS AND INVESTIGATORS. IN 2011, $348,000 IN FUNDING PROVIDED TWO PROGRAMS FOR INDIVIDUALS INTERESTED OR CURRENTLY PRACTICING IN THE ONCOLOGY FIELD: LOAN REPAYMENT PROGRAM - THE ASCO LOAN REPAYMENT PROGRAM (LRP), FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES REPAYMENT OF QUALIFYING EDUCATIONAL DEBT TO ONCOLOGISTS, OR TO ONCOLOGY FELLOWS UPON COMPLETION OF TRAINING, WHO COMMIT TO PRACTICING ONCOLOGY IN A MEDICALLY UNDERSERVED REGION OF THE UNITED STATES. IN 2011, $280,000 FUNDED FOUR (4) TWO-YEAR LOAN REPAYMENTS. MEDICAL STUDENT ROTATION - THE ASCO MEDICAL STUDENT ROTATION (MSR), FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES 8- TO 10-WEEK CLINICAL OR CLINICAL RESEARCH ONCOLOGY ROTATIONS FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER. IN 2011, $68,000 FUNDED EIGHT (8) MSRS. ALTHOUGH A NUMBER OF PROGRAMS EXIST TO RECRUIT INDIVIDUALS UNDERREPRESENTED IN MEDICINE, FEW OF THESE PROGRAMS FOCUS SPECIFICALLY ON RECRUITMENT TO CLINICAL ONCOLOGY. ULTIMATELY, IT IS HOPED THAT INCREASING DIVERSITY IN THE CLINICAL ONCOLOGY PROFESSION WILL LEAD TO INCREASED AND IMPROVED CANCER CARE FOR UNDERSERVED POPULATIONS AS WELL AS INCREASED RESEARCH ON HEALTH DISPARITIES. THE DIVERSITY IN ONCOLOGY INITIATIVE IS PART OF THE SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE, WHICH IS DESIGNED TO SUPPORT SPECIFIC PROJECTS ADDRESSING QUALITY CANCER CARE ISSUES, INCLUDING CANCER WORKFORCE, ACCESS TO CARE, DISPARITIES, CLINICAL TRIALS, AND SURVIVORSHIP, WITH GENERAL APPLICABILITY TO BREAST CANCER.	Description

Activity Other ActivityOther

Field	Value	IRS element (for citing)
Expense	363264	Expense
Grants	347044	Grants
Description	PATIENT EDUCATION AND INFORMATION-WELL-INFORMED, EDUCATED PATIENTS ARE THEIR OWN BEST ADVOCATES, AS WELL AS INVALUABLE PARTNERS FOR DOCTORS. CCF SUPPORTS BOTH DOCTORS AND PATIENTS BY FUNDING ACCURATE, DOCTOR-APPROVED CANCER INFORMATION, WHICH IS AVAILABLE PUBLICLY BOTH IN PRINT AND ONLINE, TO PROVIDE TRUSTED, AUTHORITATIVE INFORMATION TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND ABOUT THEM. FUNDING IN THIS AREA ALLOWS CCF TO CONTINUE AND EXPAND OUR WORK TO INFORM PATIENTS.HIGHLIGHTS OF PATIENT EDUCATION AND INFORMATION PROGRAMS AND ACTIVITIES SUPPORTED BY CCF IN 2011 INCLUDE:PATIENT ADVOCATE SCHOLARSHIP PROGRAM- THE PATIENT ADVOCATE SCHOLARSHIP PROGRAM PROVIDES TRAVEL GRANTS TO A SELECT NUMBER OF PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND ASCO DISEASE-SPECIFIC SYMPOSIA. IN 2011, CCF SUPPORTED THE ATTENDANCE OF PATIENT ADVOCATES AT THE 2011 ASCO ANNUAL MEETING AND ASCO DISEASE-SPECIFIC SYMPOSIA.ANSWERS TO CANCER PUBLIC FORUM- HELD DURING THE ASCO ANNUAL MEETING, THE PUBLIC FORUM IS AN IMPORTANT PROGRAM DESIGNED TO BRING PEOPLE AFFECTED BY CANCER TOGETHER TO LEARN FROM EACH OTHER, LEAN ON EACH OTHER, AND DISCUSS THE LATEST DISCOVERIES IN CANCER TREATMENT AND SURVIVORSHIP WITH THE WORLD'S TOP THOUGHT LEADERS IN CANCER CARE.CANCER.NET- CANCER.NET INCLUDES PEER-REVIEWED INFORMATION ON MORE THAN 124 TYPES OF CANCER AND SYNDROMES, INCLUDING RISK FACTORS, DIAGNOSIS, FINDING AN ONCOLOGIST , TREATMENT, MANAGING SIDE EFFECTS, CLINICAL TRIALS, AND AFTER TREATMENT, CAREGIVING, COPING STRATEGIES, AND SURVIVORSHIP. INFORMATION IS DELIVERED IN WRITTEN ARTICLES, VIDEOS, AND AUDIO PODCASTS. THIS INFORMATION IS MADE AVAILABLE FREE TO THE PUBLIC. IN 2011, THERE WERE MORE THAN 7,000,000 PAGE VIEWS OF CANCER.NET.CCF CONTINUES TO SUPPORT THE PRODUCTION OF ASCO'S PRINTED PATIENT INFORMATION MATERIALS, SUCH AS: ASCO ANSWERS FACT SHEETS- ASCO ANSWERS IS A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC. EACH FACT SHEET INCLUDES AN OVERVIEW OF THE SUBJECT, TERMS TO KNOW, AND QUESTIONS TO ASK THE DOCTOR. PATIENT GUIDES- PATIENT GUIDES ARE PRINTED BOOKLETS CONTAINING COMPREHENSIVE CANCER INFORMATION; INCLUDING AN OVERVIEW OF SPECIFIC CANCER TYPES, SYMPTOMS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIALS, AND AFTER TREATMENT.INTERNATIONAL PROGRAMS-ASCO AND THE CONQUER CANCER FOUNDATION SHARE AN INTERNATIONAL MISSION TO ENGAGE THE PHYSICIAN AND HEALTHCARE PROFESSIONAL COMMUNITY ON A GLOBAL SCALE TO IMPROVE CARE TO CANCER PATIENTS AND ENHANCE THE EXCHANGE OF KNOWLEDGE TO FACILITATE ADVANCES IN THE CARE OF PEOPLE WITH CANCER EVERYWHERE. FOUNDATION FUNDS SUPPORT INTERNATIONAL PROGRAMS INCLUDING EDUCATION, FELLOWSHIP AND GRANT OPPORTUNITIES TO ENABLE ONCOLOGISTS FROM OPPOSITE ENDS OF THE WORLD TO SHARE IDEAS AND BUILD LASTING COLLABORATIONS THAT CAN ENHANCE PATIENT CARE LOCALLY AND GLOBALLY. CCF SUPPORTS THESE PROGRAMS THROUGH ITS INTERNATIONAL PROGRAM MISSION AS WELL AS THROUGH CCF'S OTHER MISSION AREAS (RESEARCH, PROFESSIONAL EDUCATION, PATIENT EDUCATION AND INFORMATION AND QUALITY AND ACCESS TO CARE).CCF FUNDS SPECIFICALLY SUPPORTING INTERNATIONAL ACTIVITIES INCLUDE: LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE) PROVIDES EARLY-CAREER ONCOLOGISTS IN DEVELOPING NATIONS THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION. THROUGH A ONE OR TWO YEAR FELLOWSHIP THE RECIPIENT WILL EARN VALUABLE TRAINING AND EXPERIENCE WITH WHICH THEY CAN AFFECT CHANGE IN CANCER CARE IN THEIR HOME COUNTRY. RECIPIENTS MUST RETURN TO THEIR HOME INSTITUTIONS AFTER COMPLETING THEIR FELLOWSHIP AND ARE EXPECTED TO DISSEMINATE THE KNOWLEDGE THEY HAVE GAINED.INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE CONTINUING MEDICAL EDUCATION, ASSIST IN CAREER DEVELOPMENT AND HELP TO ESTABLISH STRONG RELATIONSHIPS WITH LEADING ASCO MEMBERS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT, TO ENHANCE THE QUALITY OF CANCER CARE WORLDWIDE. ADVANCED CANCER COURSES (ACC)-THE ADVANCED CANCER COURSES ARE CAREFULLY DESIGNED TO FILL THE NEED FOR ADVANCED LEARNING FOR INTERNATIONAL ONCOLOGISTS. THESE COURSES CAN BE CHOSEN FROM ASCO'S PORTFOLIO OF EDUCATIONAL PRODUCTS, OR DEVELOPED WITH THE COLLABORATION OF VOLUNTEER ONCOLOGISTS.	Description

Field	Value	IRS element (for citing)
Total Of Other Program Service Exp	363264	TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt	347044	TotalOfOtherProgramServiceGrnt
Total Program Service Expense	17757453	TotalProgramServiceExpense
Described In501 C3	1	DescribedIn501C3
Schedule B Required	1	ScheduleBRequired
Political Activities	0	PoliticalActivities
Lobbying Activities	0	LobbyingActivities
Subject To Proxy Tax	0	SubjectToProxyTax
Donor Advised Funds	0	DonorAdvisedFunds
Conservation Easements	0	ConservationEasements
Collections Of Art	0	CollectionsOfArt
Credit Counseling	0	CreditCounseling
Term Or Permanent Endowments	1	TermOrPermanentEndowments
Report Land Bldg Equip	0	ReportLandBldgEquip
Report Invest Oth Securities	0	ReportInvestOthSecurities
Report Prog Rel Invest	0	ReportProgRelInvest
Report Other Assets	0	ReportOtherAssets
Report Other Liabilities	1	ReportOtherLiabilities
Report Fin48 Footnote	1	ReportFin48Footnote
Independent Audit Financial Stmt	0	IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt	1	ConsolidatedAuditFinancialStmt
School	0	School
Foreign Office	0	ForeignOffice
Foreign Activities	1	ForeignActivities
More Than5000 K To Organizations	1	MoreThan5000KToOrganizations
More Than5000 K To Individuals	1	MoreThan5000KToIndividuals
Professional Fundraising	1	ProfessionalFundraising
Fundraising Activities	0	FundraisingActivities
Gaming	0	Gaming
Hospital	0	Hospital
Grants To Organizations	1	GrantsToOrganizations
Grants To Individuals	1	GrantsToIndividuals
Schedule J Required	1	ScheduleJRequired
Tax Exempt Bonds	0	TaxExemptBonds
Excess Benefit Transaction	0	ExcessBenefitTransaction
Prior Excess Benefit Transaction	0	PriorExcessBenefitTransaction
Loan To Officer Or DQP	0	LoanToOfficerOrDQP
Grant To Related Person	0	GrantToRelatedPerson
Bsnss Rltnshp With Organization	0	BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member	0	BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp	0	OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions	0	DeductibleNonCashContributions
Deductible Contributions Of Art	0	DeductibleContributionsOfArt
Terminated	0	Terminated
Partial Liquidation	0	PartialLiquidation
Disregarded Entity	0	DisregardedEntity
Related Entity	1	RelatedEntity
Related Org Controlled Entity	0	RelatedOrgControlledEntity
Transaction Related Entity	0	TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org	0	TransfersToExemptNonChrtblOrg
Activities Conducted Partnership	0	ActivitiesConductedPartnership
Schedule O Required	1	ScheduleORequired
Number Forms Transmitted With1096	232	NumberFormsTransmittedWith1096
Number W2 G Included	0	NumberW2GIncluded
Compliance With Backup Witholding	1	ComplianceWithBackupWitholding
Number Of Employees	0	NumberOfEmployees
Unrelated Business Income	0	UnrelatedBusinessIncome
Foreign Financial Account	0	ForeignFinancialAccount
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTrans
Taxable Party Notification	0	TaxablePartyNotification
Non Deductible Contributions	0	NonDeductibleContributions
Quid Pro Quo Contributions	0	QuidProQuoContributions
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOf
Funds To Pay Premiums	0	FundsToPayPremiums
Premiums Paid	0	PremiumsPaid
Indoor Tanning Services	0	IndoorTanningServices
Info In Schedule O Part VI	X	InfoInScheduleOPartVI
Nbr Voting Governing Body Members	12	NbrVotingGoverningBodyMembers
Number Independent Voting Members	11	NumberIndependentVotingMembers
Family Or Business Relationship	0	FamilyOrBusinessRelationship
Delegation Of Management Duties	0	DelegationOfManagementDuties
Changes To Organizing Docs	1	ChangesToOrganizingDocs
Material Diversion Or Misuse	0	MaterialDiversionOrMisuse
Members Or Stockholders	0	MembersOrStockholders
Election Of Board Members	1	ElectionOfBoardMembers
Decisions Subject To Approval	1	DecisionsSubjectToApproval
Minutes Of Governing Body	1	MinutesOfGoverningBody
Minutes Of Committees	1	MinutesOfCommittees
Officer Mailing Address	0	OfficerMailingAddress
Local Chapters	0	LocalChapters
Form990 Provided To Governing Body	1	Form990ProvidedToGoverningBody
Conflict Of Interest Policy	1	ConflictOfInterestPolicy
Annual Disclosure Covered Persons	1	AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement	1	RegularMonitoringEnforcement
Whistleblower Policy	1	WhistleblowerPolicy
Document Retention Policy	1	DocumentRetentionPolicy
Compensation Process CEO	1	CompensationProcessCEO
Compensation Process Other	1	CompensationProcessOther
Investment In Joint Venture	0	InvestmentInJointVenture
States Where Copy Of Return Is Filed	AL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AZ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ME	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	FL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	GA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	HI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	IL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MD	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NJ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NM	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ND	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	PA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	RI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	SC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	TN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	UT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	VA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WV	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WI	StatesWhereCopyOfReturnIsFiled
Own Website	X	OwnWebsite

The Books Are In Care Of TheBooksAreInCareOf

Field	Value	IRS element (for citing)
Name Person	PAUL AINES CFO	NamePerson
Telephone Number	5714831700	TelephoneNumber

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	SAME AS C ABOVE	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (16 entries)

TitleTitle	Average Hours Per WeekAverageHoursPerWeek	Individual Trustee Or DirectorIndividualTrusteeOrDirector	OfficerOfficer	Reportable Comp From OrganizationReportableCompFromOrganization	Reportable Comp From Related OrgsReportableCompFromRelatedOrgs	Other CompensationOtherCompensation
MARTIN J MURPHY JR PHD DMEDSC
CHAIR	1.00	X	X	0	0	0
RICHARD L SCHILSKY MD
SECRETARY	1.00	X	X	0	0	0
ALLEN LICHTER MD
BOARD MEMBER; CEO	4.00	X	X	0	748894	20162
W CHARLES PENLEY MD
TREASURER	1.00	X	X	0	0	0
JOHN H GLICK MD
BOARD MEMBER	1.00	X		0	0	0
NORA ANITA JANJAN MD
BOARD MEMBER	1.00	X		750	0	0
ROBERT J MAYER MD
BOARD MEMBER	1.00	X		0	0	0
THOMAS A MARSLAND MD
BOARD MEMBER	1.00	X		0	0	0
SANDRA M SWAIN MD
BOARD MEMBER	1.00	X		0	0	0
IRA M ELEGANT ESQ
BOARD MEMBER	1.00	X		0	0	0
LAWRENCE H EINHORN MD
BOARD MEMBER	1.00	X		0	0	0
GABRIEL N HORTOBAGYI MD FACP
BOARD MEMBER	1.00	X		0	0	0
MICHAEL P LINK MD
BOARD MEMBER	1.00	X		0	10000	0
NANCY DALY MS MPH
BOARD MEMBER; CCF EXEC DIR	37.50	X	X	0	210524	23931
DINA MICHELS ESQ
GENERAL COUNSEL	4.00		X	0	468167	34067
PAUL AINES CPA
CFO	4.00		X	0	287362	32951

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	750	TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs	1724947	TotalReportableCompFrmRltdOrgs
Total Other Compensation	111111	TotalOtherCompensation
Number Individuals GT100 K	0	NumberIndividualsGT100K
Formers Listed	0	FormersListed
Total Comp GT150 K	1	TotalCompGT150K
Compensation From Other Sources	0	CompensationFromOtherSources

Contractor Compensation ContractorCompensation (2 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1	CityAddressOfContractor/AddressUS/City	StateAddressOfContractor/AddressUS/State	ZIP CodeAddressOfContractor/AddressUS/ZIPCode	Description Of ServicesDescriptionOfServices	CompensationCompensation
GRAHAM PELTON
39 BEACHWOOD ROAD	SUMMIT	NJ	07901	FUNDRAISING CONSULTING	534850
THE MERZ GROUP
1570 MCDANIEL DR	WEST CHESTER	PA	19380	BRAND CONSULTANT	168185

Field	Value	IRS element (for citing)
Number Of Contractors GT100 K	2	NumberOfContractorsGT100K
Federated Campaigns	11453	FederatedCampaigns
Related Organizations	2374454	RelatedOrganizations
All Other Contributions	20684608	AllOtherContributions
Noncash Contributions	5450	NoncashContributions
Total Contributions	23070515	TotalContributions

Investment Income InvestmentIncome

Field	Value	IRS element (for citing)
Total Revenue Column	731080	TotalRevenueColumn
Exclusion	$731,080	ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

Field	Value	IRS element (for citing)
Securities	14386041	Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

Field	Value	IRS element (for citing)
Securities	14214641	Securities

Gain Or Loss GainOrLoss

Field	Value	IRS element (for citing)
Securities	171400	Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

Field	Value	IRS element (for citing)
Total Revenue Column	171400	TotalRevenueColumn
Exclusion	$171,400	ExclusionAmount

Total Revenue TotalRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	23972995	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$902,480	ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

Field	Value	IRS element (for citing)
Total	15342976	Total
Program Services	15342976	ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

Field	Value	IRS element (for citing)
Total	626669	Total
Program Services	626669	ProgramServices

Foreign Grants ForeignGrants

Field	Value	IRS element (for citing)
Total	267500	Total
Program Services	267500	ProgramServices

Fees For Services Management FeesForServicesManagement

Field	Value	IRS element (for citing)
Total	2551170	Total
Program Services	1403144	ProgramServices
Management And General	438801	ManagementAndGeneral
Fundraising	709225	Fundraising

Fees For Services Legal FeesForServicesLegal

Field	Value	IRS element (for citing)
Total	9812	Total
Management And General	9812	ManagementAndGeneral

Fees For Services Accounting FeesForServicesAccounting

Field	Value	IRS element (for citing)
Total	5000	Total
Management And General	5000	ManagementAndGeneral

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	534850	Total
Fundraising	534850	Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

Field	Value	IRS element (for citing)
Total	135273	Total
Management And General	135273	ManagementAndGeneral

Fees For Services Other FeesForServicesOther

Field	Value	IRS element (for citing)
Total	37788	Total
Management And General	37788	ManagementAndGeneral

Advertising Advertising

Field	Value	IRS element (for citing)
Total	529786	Total
Fundraising	529786	Fundraising

Office Expenses OfficeExpenses

Field	Value	IRS element (for citing)
Total	98556	Total
Program Services	19426	ProgramServices
Management And General	19999	ManagementAndGeneral
Fundraising	59131	Fundraising

Information Technology InformationTechnology

Field	Value	IRS element (for citing)
Total	24857	Total
Management And General	24857	ManagementAndGeneral

Occupancy Occupancy

Field	Value	IRS element (for citing)
Total	231180	Total
Program Services	64268	ProgramServices
Management And General	39763	ManagementAndGeneral
Fundraising	127149	Fundraising

Travel Travel

Field	Value	IRS element (for citing)
Total	180459	Total
Program Services	14621	ProgramServices
Management And General	113720	ManagementAndGeneral
Fundraising	52118	Fundraising

Conferences Meetings ConferencesMeetings

Field	Value	IRS element (for citing)
Total	34151	Total
Management And General	34151	ManagementAndGeneral

Other Expenses OtherExpenses (4 entries)

DescriptionDescription	TotalTotal	Program ServicesProgramServices	Management And GeneralManagementAndGeneral	FundraisingFundraising
DUES & SUBSCRIPTIONS	61419	14745	44414	2260
POSTAGE	46943	609	889	45445
BANK & CREDIT CARD FEES	36413		36413
PRINTING & DISTRIBUTION	16685	3495	13190

Total Functional Expenses TotalFunctionalExpenses

Field	Value	IRS element (for citing)
Total	20771487	Total
Program Services	17757453	ProgramServices
Management And General	954070	ManagementAndGeneral
Fundraising	2059964	Fundraising

Cash Non Interest Bearing CashNonInterestBearing

Field	Value	IRS element (for citing)
BOY	-1446413	BOY
EOY	4575939	EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

Field	Value	IRS element (for citing)
BOY	7295112	BOY
EOY	668951	EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

Field	Value	IRS element (for citing)
BOY	6725883	BOY
EOY	6883142	EOY

Accounts Receivable AccountsReceivable

Field	Value	IRS element (for citing)
BOY	1133	BOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

Field	Value	IRS element (for citing)
BOY	30450	BOY
EOY	81934	EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

Field	Value	IRS element (for citing)
BOY	21727452	BOY
EOY	24760586	EOY

Investments Other Securities InvestmentsOtherSecurities

Field	Value	IRS element (for citing)
BOY	1454926	BOY
EOY	9936	EOY

Other Assets Total OtherAssetsTotal

Field	Value	IRS element (for citing)
BOY	396529	BOY

Total Assets TotalAssets

Field	Value	IRS element (for citing)
BOY	36185072	BOY
EOY	36980488	EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

Field	Value	IRS element (for citing)
BOY	7386469	BOY
EOY	6381439	EOY

Deferred Revenue DeferredRevenue

Field	Value	IRS element (for citing)
BOY	1306001	BOY
EOY	1684113	EOY

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
BOY	1058340	BOY
EOY	565454	EOY

Total Liabilities TotalLiabilities

Field	Value	IRS element (for citing)
BOY	9750810	BOY
EOY	8631006	EOY

Field	Value	IRS element (for citing)
Follow SFAS117	X	FollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	17511782	BOY
EOY	18703836	EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	8840239	BOY
EOY	9558405	EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	82241	BOY
EOY	87241	EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	26434262	BOY
EOY	28349482	EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	36185072	BOY
EOY	36980488	EOY

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	X	InfoInScheduleOPartXI
Reconcilation Revenue Expenses	3201508	ReconcilationRevenueExpenses
Reconcilation Other Changes	-1286288	ReconcilationOtherChanges
Info In Schedule O Part XII	X	InfoInScheduleOPartXII
Method Of Accounting Accrual	X	MethodOfAccountingAccrual
Accountant Compile Or Review	0	AccountantCompileOrReview
FS Audited	1	FSAudited
Audit Committee	1	AuditCommittee
Financial Statement Consolidated	X	FinancialStatementConsolidated
Federal Grant Audit Required	0	FederalGrantAuditRequired

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org170b1 Avi	X	PubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	5055674	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	32873924	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	24169849	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	24400007	CurrentTaxYearMinus1Year
Current Tax Year	23206830	CurrentTaxYear
Total	109706284	Total

Total170 Total170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	5055674	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	32873924	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	24169849	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	24400007	CurrentTaxYearMinus1Year
Current Tax Year	23206830	CurrentTaxYear
Total	109706284	Total

Field	Value	IRS element (for citing)
Amounts Subst Contributors Total	44405451	AmountsSubstContributorsTotal
Public Support Total170	65300833	PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	238350	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	481663	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	195182	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	136059	CurrentTaxYearMinus1Year
Current Tax Year	595807	CurrentTaxYear
Total	1647061	Total

Field	Value	IRS element (for citing)
Total Support	111353345	TotalSupport
Public Support Pertcentage170	0.58640	PublicSupportPertcentage170
Public Support Pertcent Prior Year	0.54970	PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170	X	ThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

Field	Value	IRS element (for citing)
Contributor Number	RESTRICTED	ContributorNumber

Contributor Name Business ContributorNameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor Address US ContributorAddressUS

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Aggregate Contributions	RESTRICTED	AggregateContributions

Schedule D IRS990ScheduleD

Current Year CurrentYear

Field	Value	IRS element (for citing)
Beginning Of Year Balance	82241	BeginningOfYearBalance
Contributions	5000	Contributions
Investment Earnings Or Losses	-2594	InvestmentEarningsOrLosses
Grants Or Scholarships	1948	GrantsOrScholarships
End Of Year Balance	82699	EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

Field	Value	IRS element (for citing)
Beginning Of Year Balance	116963	BeginningOfYearBalance
Contributions	15930	Contributions
Investment Earnings Or Losses	1348	InvestmentEarningsOrLosses
Grants Or Scholarships	52000	GrantsOrScholarships
End Of Year Balance	82241	EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	103356	BeginningOfYearBalance
Contributions	14492	Contributions
Investment Earnings Or Losses	1115	InvestmentEarningsOrLosses
Grants Or Scholarships	2000	GrantsOrScholarships
End Of Year Balance	116963	EndOfYearBalance

Current Year Minus3 Years CurrentYearMinus3Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	154283	BeginningOfYearBalance
Investment Earnings Or Losses	6573	InvestmentEarningsOrLosses
Grants Or Scholarships	57500	GrantsOrScholarships
End Of Year Balance	103356	EndOfYearBalance

Field	Value	IRS element (for citing)
Board Designated EOY Balance	0.00000	BoardDesignatedEOYBalance
Permanent Endowment EOY Balance	1.00000	PermanentEndowmentEOYBalance
Term Endowment EOY Balance	0.00000	TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs	0	EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs	0	EndowmentsHeldByRelatedOrgs
Total Of Book Value Land Buildings	0	TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
Description	DUE TO RELATED ORGANIZATION	Description
Amount	$565,454	Amount

Field	Value	IRS element (for citing)
Total Of Amounts	565454	TotalOfAmounts
Total Revenue	23972995	TotalRevenue
Total Expenses	20771487	TotalExpenses
Excess Or Deficit For Year	3201508	ExcessOrDeficitForYear
Net Unrealized GL On Investments	-1286288	NetUnrealizedGLOnInvestments
Total Adjustments	-1286288	TotalAdjustments
Excess Or Deficit Per FS	1915220	ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt	22551434	TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments	-1286288	NetUnrealizedGainsInvestments
Revenue Not Rptd F990	-1286288	RevenueNotRptdF990
Revenue Subtotal	23837722	RevenueSubtotal
Investment Expenses Not Included	135273	InvestmentExpensesNotIncluded
Revenue Not Rptd On Fin Stmt	135273	RevenueNotRptdOnFinStmt
Total Revenue Per Form990	23972995	TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt	20636214	TotExpensesEtcAuditedFinclStmt
Expenses Not Rptd F990	0	ExpensesNotRptdF990
Expenses Subtotal	20636214	ExpensesSubtotal
Investment Expenses Not Included2	135273	InvestmentExpensesNotIncluded2
Expenses Not Rptd On Fin Stmt	135273	ExpensesNotRptdOnFinStmt
Total Expenses Per Form990	20771487	TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (3 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:	PART V, LINE 4:	PERMANENTLY RESTRICTED NET ASSETS OF DONOR-RESTRICTED ENDOWMENT FUNDS ARE PRESERVED, ABSENT EXPLICIT DIRECTION FROM THE DONOR. PART V, LINE 1A-1G: ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS.
DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:	PART X:	THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. AT A MINIMUM, THE 2008 THROUGH 2011 TAX YEARS ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES.
		PART IV; QUESTION 4 - INTEREST FROM THE PERMANENTLY RESTRICTED FUNDS IS INTENDED TO FUND FUTURE RESEARCH AND/OR EDUCATIONAL AWARDS.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	1	GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (4 entries)

RegionRegion	Type Of Activities ConductedTypeOfActivitiesConducted	Specific Services ProvidedSpecificServicesProvided	Total ExpendituresTotalExpenditures
NORTH AMERICA	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S), PROGRAM SERVICES	MERIT AWARDS ($21,000) AND YOUNG INVESTIGATOR AWARD ($150,000)	171000
EAST ASIA & THE PACIFIC	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S), PROGRAM SERVICES	MERIT AWARDS ($12,000) AND YOUNG INVESTIGATOR AWARD ($50,000)	60500
EUROPE	GRANTS ISSUED TO INDIVIDUALS, PROGRAM SERVICES	MERIT AWARDS ($33,000)	33000
SOUTH AMERICA	GRANTS ISSUED TO INDIVIDUAL, PROGRAM SERVICES	MERIT AWARD ($3,000)	3000

Field	Value	IRS element (for citing)
Subtotal Number Of Offices	0	SubtotalNumberOfOffices
Subtotal Number Of Employees	0	SubtotalNumberOfEmployees
Cont Number Of Offices	0	ContNumberOfOffices
Cont Number Of Employees	0	ContNumberOfEmployees
Total Number Of Offices	0	TotalNumberOfOffices
Total Number Of Employees	0	TotalNumberOfEmployees
Subtotal Amount Spent	267500	SubtotalAmountSpent
Cont Amount Spent	0	ContAmountSpent
Total Amount Spent	267500	TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (4 entries)

RegionRegion	Purpose Of GrantPurposeOfGrant	Amount Of Cash GrantAmountOfCashGrant
EAST ASIA & THE PACIFIC	YOUNG INVESTIGATOR AWARD (YIA)	50000
NORTH AMERICA	YOUNG INVESTIGATOR AWARD (YIA)	50000
NORTH AMERICA	YOUNG INVESTIGATOR AWARD (YIA)	50000
NORTH AMERICA	YOUNG INVESTIGATOR AWARD (YIA)	50000

Field	Value	IRS element (for citing)
Total Number Of501c3 Orgs	0	TotalNumberOf501c3Orgs
Total Number Of Other Orgs	4	TotalNumberOfOtherOrgs

Grants To Ind Outside US GrantsToIndOutsideUS (4 entries)

Type Of AssistanceTypeOfAssistance	RegionRegion	Number Of RecipientsNumberOfRecipients	Amount Of Cash GrantAmountOfCashGrant
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	EAST ASIA & PACIFIC	7	10500
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	NORTH AMERICA	14	21000
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	EUROPE	22	33000
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	SOUTH AMERICA	2	3000

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	0	TransferToForeignCorp
Interest In Foreign Trust	0	InterestInForeignTrust
Own Foreign Corp	0	OwnForeignCorp
Passive Foreign Invest Co	0	PassiveForeignInvestCo
Foreign Partnership	0	ForeignPartnership
Boycott Countries	0	BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV (2 entries)

IdentifierIdentifier

ExplanationExplanation

PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:

SCHEDULE F, PART I, LINE 2: CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS OF REVIEW CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET SUCH TIME SCHEDULES AS MAY HAVE BEEN PROPOSED. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES IN THE GRANT BUDGET ARE SUBJECT TO THE REVIEW AND APPROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 60 DAYS FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 60 DAYS FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.

SCHEDULE F, PART II, LINE 1; DESCRIPTION OF AWARDS DISTRIBUTED YOUNG INVESTIGATOR AWARD (YIA) PROVIDES FUNDING TO PROMISING INVESTIATORS TO ENCOURAGE AND PROMOTE QUALITY RESEARCH IN CLINICAL ONCOLOGY. THE PURPOSE OF THIS AWARD IS TO FUND PHYSICIANS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. TOTAL GRANT: $50,000 OVER ONE YEAR. MERIT AWARDS ARE DESIGNED TO FURTHER PROMOTE CLINICAL RESEARCH BY YOUNG SCIENTISTS AND TO PROVIDE FELLOWS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS. A SELECT NUMBER OF CCF MERIT AWARDS ARE GIVEN ANNUALLY TO RECOGNIZE OUTSTANDING ABSTRACTS SUBMITTED FOR CONSIDERATION FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING. THE AWARDS ARE GIVE TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON SELECTED ABSTRACTS, AND THE CRITERIA ARE DESCRIBED IN THE ELIGIBILITY AND AWARD TERMS SECTIONS.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	X	MailSolicitations
Email Solicitations	X	EmailSolicitations
Phone Solicitations	X	PhoneSolicitations
In Person Solicitations	X	InPersonSolicitations
Solicitation Of Non Govt Grants	X	SolicitationOfNonGovtGrants
Agreement Ref Fundraising	1	AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation

Field	Value	IRS element (for citing)
Name Of Individual	GRAHAM PELTON	NameOfIndividual

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	39 BEACHWOOD RD	AddressLine1
City	SUMMIT	City
State	NJ	State
ZIP Code	07901	ZIPCode

Field	Value	IRS element (for citing)
Activity	FUNDRAISING CONSULTING	Activity
Fundraiser Control Of Funds	0	FundraiserControlOfFunds
Gross Receipts	0	GrossReceipts
Amount Retained By Contractor	534850	AmountRetainedByContractor
Net To Organization	-534850	NetToOrganization

Field	Value	IRS element (for citing)
Total Retained By Contractors	534850	TotalRetainedByContractors
Total Net To Organization	-534850	TotalNetToOrganization
Licensed States	AL	LicensedStates
Licensed States	AK	LicensedStates
Licensed States	AZ	LicensedStates
Licensed States	AR	LicensedStates
Licensed States	CA	LicensedStates
Licensed States	CO	LicensedStates
Licensed States	CT	LicensedStates
Licensed States	DE	LicensedStates
Licensed States	FL	LicensedStates
Licensed States	GA	LicensedStates
Licensed States	HI	LicensedStates
Licensed States	ID	LicensedStates
Licensed States	IL	LicensedStates
Licensed States	IN	LicensedStates
Licensed States	IA	LicensedStates
Licensed States	KS	LicensedStates
Licensed States	KY	LicensedStates
Licensed States	LA	LicensedStates
Licensed States	ME	LicensedStates
Licensed States	MD	LicensedStates
Licensed States	MA	LicensedStates
Licensed States	MI	LicensedStates
Licensed States	MN	LicensedStates
Licensed States	MS	LicensedStates
Licensed States	MO	LicensedStates
Licensed States	MT	LicensedStates
Licensed States	NE	LicensedStates
Licensed States	NV	LicensedStates
Licensed States	NH	LicensedStates
Licensed States	NJ	LicensedStates
Licensed States	NM	LicensedStates
Licensed States	NY	LicensedStates
Licensed States	NC	LicensedStates
Licensed States	ND	LicensedStates
Licensed States	OH	LicensedStates
Licensed States	OK	LicensedStates
Licensed States	OR	LicensedStates
Licensed States	PA	LicensedStates
Licensed States	RI	LicensedStates
Licensed States	SC	LicensedStates
Licensed States	SD	LicensedStates
Licensed States	TN	LicensedStates
Licensed States	TX	LicensedStates
Licensed States	UT	LicensedStates
Licensed States	VT	LicensedStates
Licensed States	VA	LicensedStates
Licensed States	WA	LicensedStates
Licensed States	WV	LicensedStates
Licensed States	WI	LicensedStates
Licensed States	WY	LicensedStates

Form990 Schedule G Part IV Form990ScheduleGPartIV

Field	Value	IRS element (for citing)
Identifier	EXPLANATION OF FUNDRAISING PAYMENTS	Identifier
Return Reference	SCHEDULE G, PART I, LINE 2B, COLUMN (V)	ReturnReference
Explanation	PAYMENTS MADE TO GRAHAM PELTON CONSULTING WERE FOR FUNDRAISING GUIDANCE ON BEST PRACTICE METHODS OF EFFECTIVE AND EFFICIENT FUNDRAISING. CCF'S RELATED ORGANIZATION, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO), ALSO PAID COSTS FOR FUNDRAISING SERVICES PROVIDED TO CCF, WHICH ARE REFLECTED IN THE IRS FORM 990 OF ASCO.	Explanation

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Records Maintained	1	RecordsMaintained

Recipient Table RecipientTable (47 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EIN Of RecipientEINOfRecipient	IRC SectionIRCSection	Amount Of Cash GrantAmountOfCashGrant	Purpose Of GrantPurposeOfGrant	Address Line2AddressUS/AddressLine2
BAYLOR COLLEGE OF MEDICINE
ONE BAYLOR PLAZA	HOUSTON	TX	77030	741613878	501 (C)(3)	400000	CAREER DEVELOPMENT AWARDS
BENAROYA RESEARCH INSTITUTE
1100 NINTH AVENUE	SEATTLE	WA	98101	910653422	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS
210 W MCKINLEY AVE	DECATUR	IL	62521	371160364	501 (C)(3)	30000	COMMUNITY ONCOLOGY RESEARCH GRANT
COLUMBIA UNIVERSITY
177 FT WASHINGTON AVE	NEW YORK	NY	10032	131924236	501 (C)(3)	1470000	IMPROVING CANCER CARE GRANT, YOUNG INVESTIGATOR AWARD, LOAN REPAYMENT PROGRAM
DANA-FARBER CANCER INSTITUTE
44 BINNEY STREET BP431C	BOSTON	MA	02115	042263040	501 (C)(3)	300000	YOUNG INVESTIGATOR AWARDS AND CAREER DEVELOPMENT AWARDS
CHILDREN'S NATIONAL MEDICAL CENTER
111 MICHIGAN AVE NW	WASHINGTON	DC	20010	521640403	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF CALIFORNIA - IRVINE
101 THE CITY DRIVE SOUTH	ORANGE	CA	92868	952321786	501 (C)(3)	200000	CAREER DEVELOPMENT AWARD
JOHNS HOPKINS UNIVERSITY
550 NORTH BROAKWAY SUITE 1003	BALTIMORE	MD	212052009	520591627	501 (C)(3)	265000	YOUNG INVESTIGATOR AWARDS, LONG-TERM INTERNATIONAL FELLOWS
FLORIDA SOCIETY OF CLINICAL ONCOLOGY
10022 WATER WORKS LANE	RIVERVIEW	FL	33578	592305471	501 (C)(3)	10000	STATE AFFILIATE GRANT PROGRAM
GEORGE WASHINGTON UNIVERSITY
GEORGE WASHINGTON UNIVERSITY	WASHINGTON	DC	20037	530196584	501 (C)(3)	5000	MEDICAL STUDENT ROTATION AWARD
MEMORIAL SLOAN-KETTERING CANCER CENTER
GENERAL POST OFFICE BOX 263633	NEW YORK	NY	10017	131924236	501 (C)(3)	700000	YOUNG INVESTIGATOR AWARDS, CAREER DEVELOPMENT AWARDS	THIRD AVE
GEORGIA SOCIETY OF CLINICAL ONCOLOGY
3330 CUMBERLAND BLVD	ATLANTA	GA	30339	581752866	501 (C)(6)	10000	STATE AFFILIATE GRANT PROGRAM
INDIANA UNIVERSITY
420 UNIVERSITY BLVD	INDIANAPOLIS	IN	46202	135600673	501 (C)(3)	450000	ADVANCED CLINICAL RESEARCH AWARD
OHIO STATE UNIVERSITY
901 WOODY HAYES DR	COLUMBUS	OH	43210	890330467	501 (C)(3)	255000	YOUNG INVESTIGATOR AWARDS, MEDICAL STUDENT ROTATION AWARD
UNIVERSITY OF MICHIGAN
102 OBSERVATORY	ANN ARBOR	MI	481090723	386006309	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
LINCOLN MEDICAL AND MENTAL HEALTH CENTER
E 149TH STREET	BRONX	NY	10451	133040671	GOV'T ENTITY	70000	LOAN REPAYMENT PROGRAM
UNIVERSITY OF CALIFORNIA - SAN FRANCISCO
3333 CALIFORNIA STREET	SAN FRANCISCO	CA	94118	942829914	501 (C)(3)	150000	YOUNG INVESTIGATOR AWARDS
MAYO CLINIC
13400 EAST SHEA BLVD	SCOTTSDALE	AZ	85259	860800150	501 (C)(3)	200000	CAREER DEVELOPMENT AWARD
MEDICAL COLLEGE OF WISCONSIN
8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	390806261	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
MEDICAL UNIVERSITY OF SOUTH CAROLINA
86 JONATHAN LUCAS STREET	CHARLESTON	SC	29425	576000722	501 (C)(3)	200000	CAREER DEVELOPMENT AWARD
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET	PHILADELPHIA	PA	19104	231352685	501 (C)(3)	105000	YOUNG INVESTIGATOR AWARDS, MEDICAL STUDENT ROTATION AWARD
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
PO BOX 4486	HOUSTON	TX	77210	746000203	501 (C)(3)	565000	CAREER DEVELOPMENT AWARDS, LONG-TERM INTERNATIONAL FELLOWS AWARD
UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUE	CHICAGO	IL	60637	362177139	501 (C)(3)	600000	YOUNG INVESTIGATOR AWARDS, TRANSLATIONAL RESEARCH PROFESSORSHIP AWARD
MEHARRY MEDICAL COLLEGE
1005 DR D B TODD JR BLVD	NASHVILLE	TN	37208	620488046	501 (C)(3)	5000	MEDICAL STUDENT ROTATION AWARD
UNIVERSITY OF PITTSBURGH
3100 CATHEDRAL OF LEARNING	PITTSBURGH	PA	15260	125096559	501 (C)(3)	55000	YOUNG INVESTIGATOR AWARD, MEDICAL STUDENT ROTATION AWARD
MICHIGAN SOCIETY OF HEMATOLOGY & ONCOLOGY
3630 ROCKINGHAM RD	ROYAL OAK	MI	48073	382634114	501 (C)(6)	10000	STATE AFFILIATE GRANT PROGRAM
UNIVERSITY OF TEXAS SWESTERN
5323 HARRY HINES BLVD	DALLAS	TX	75390	756002868	501 (C)(3)	55000	YOUNG INVESTIGATOR AWARD, MEDICAL STUDENT ROTATION AWARD
NATIONAL CANCER INSTITUTE
NATIONAL CANCER INSTITUTE	BETHESDA	MD	20892	541843091	GOV'T ENTITY	100000	YOUNG INVESTIGATOR AWARDS
VANDERBILT UNIVERSITY MEDICAL CTR
1640 PHOENIX BLVD SUITE 100	COLLEGE PARK	GA	30349	620476822	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
WASHINGTON UNIVERSITY ST LOUIS
700 ROSEDALE AVE	ST LOUIS	MO	63112	430653611	501 (C)(3)	100000	YOUNG INVESTIGATOR AWARD
NATIONAL INSTITUTES OF HEALTH
33 NORTH DRIVE	BETHESDA	MD	20814	530196960	GOV'T ENTITY	50000	YOUNG INVESTIGATOR AWARD
NEWARK BETH ISRAEL MEDICAL CENTER FOUNDATION
201 LYONS AVE	NEWARK	NJ	07112	222587176	501 (C)(3)	30000	COMMUNITY ONCOLOGY RESEARCH GRANT
PEDIATRIC ONCOLOGY BRANCH NATIONAL CANCER INSTITUTE
NATIONAL INSTITUTES OF HEALTH	BETHESDA	MD	20814	520858115	GOV'T ENTITY	50000	YOUNG INVESTIGATOR AWARD
NEW MEXICO SOCIETY OF CLINICAL ONCOLOGY
1501 SAN PEDRO SE	ALBUQUERQUE	NM	87108	850392445	501 (C)(3)	10000	STATE AFFILIATE GRANT PROGRAM
ROBERT WOOD JOHNSON MEDICAL SCHOOL
675 HOES LANE WEST	NEW BRUNSWICK	NJ	08903	521358241	501 (C)(3)	5000	MEDICAL STUDENT ROTATION AWARD
TENNESSEE ONCOLOGY PRACTICE SOCIETY
11600 NEBEL STREET	ROCKVILLE	MD	20852	621445145	501 (C)(6)	10000	STATE AFFILIATE GRANT PROGRAM
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
34TH STREET AND CIVIC CENTER	PHILADELPHIA	PA	19104	231352166	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
THE CITY COLLEGE OF NEW YORK
160 CONVENT AVE	NEW YORK	NY	10031	135598093	501 (C)(3)	5000	MEDICAL STUDENT ROTATION AWARD
MASSACHUSETTS GENERAL HOSPITAL
555 FRUIT STREET	BOSTON	MA	02114	041564655	501 (C)(3)	200000	CAREER DEVELOPMENT AWARD
THE VALLEY HOSPITAL
223 N VAN DIEN AVE	RIDGEWOOD	NJ	07450	221487397	501 (C)(3)	30000	COMMUNITY ONCOLOGY RESEARCH GRANT
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1802 SIXTH AVE SOUTH	BIRMINGHAM	AL	35294	636005396	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF MARYLAND
22 SOUTH GREENE STREET	BALTIMORE	MD	21201	521362753	501 (C)(3)	70000	LOAN REPAYMENT PROGRAM
UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE
1601 NORTHWEST 12TH AVE	MIAMI	FL	33136	590624458	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF WISCONSIN
600 HIGHLAND AVE	MADISON	WI	53792	396006492	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
WEST VIRGINIA UNIVERSITY
PO BOX 9100	MORGANTOWN	WV	26506	556000842	501 (C)(3)	200000	CAREER DEVELOPMENT AWARD
YOLANDA G BARCO ONCOLOGY INSTITUTE
751 LIBERTY STREET	MEADVILLE	PA	16335	251512436	501 (C)(3)	70000	LOAN REPAYMENT PROGRAM
AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2318 MILL RD 800	ALEXANDRIA	VA	22314	136180380	501 (C)(3)	7731584	CONTRIBUTION

Field	Value	IRS element (for citing)
Total Nbr Of501 C3 And Govt Grants	44	TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations	3	TotalNbrOfOtherOrganizations

Form990 Schedule I Part III Form990ScheduleIPartIII (4 entries)

Type Of GrantTypeOfGrant	Number Of RecipientsNumberOfRecipients	Amount Of Cash GrantAmountOfCashGrant
ONCOLOGY TRAINEE TRAVEL AWARDS ALLOW FOR THE SUPPORT OF CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS BY PROVIDING THEM INDIVIDUAL TRAVEL GRANT TO DEFRAY TRAVEL EXPENSES FOR ATTENDING THE ASCO ANNUAL MEETING.	103	244000
MERIT AWARDS WERE GIVEN TO ONCOLOGY FELLOWS, WHO ARE FIRST AUTHORS ON RESEARCH REFLECTED IN ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING.	172	223000
GIANNI BONADONNA BREAST CANCER AWARD	2	60000
PATIENT ADVOCATE SCHOLARSHIP WERE PROVIDED FOR ADVOCATES TO ATTEND THE SCIENTIFIC AND EDUCATIONAL SESSIONS AT THE ASCO ANNUAL MEETING AND BREAST CANCER SYMPOSIUM.	61	99669

Form990 Schedule I Part IV Form990ScheduleIPartIV

Field	Value	IRS element (for citing)
Identifier	PROCEDURE FOR MONITORING GRANTS IN THE U.S.:	Identifier
Return Reference	PART I, LINE 2:	ReturnReference
Explanation	SCHEDULE I, PART I, LINE 2: CCF GRANTS SEVERAL SPECIAL AWARDS INTENDED TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS WHOSE COMMITMENT TO FURTHERING THE PROGRESS AGAINST CANCER HAS LED TO TREMENDOUS CONTRIBUTIONS TO THE FIELD OF CLINICAL ONCOLOGY, CANCER PATIENTS, AND ASCO, ITS RELATED ORGANIZATION. SPECIAL AWARD RECIPIENTS ARE HONORED AT AND MOST GIVE A LECTURE DURING AN ASCO MEETING OR SYMPOSIUM. SPECIAL AWARD RECIPIENTS ARE SELECTED BASED ON A PEER-REVIEW PROCESS USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH AWARD. FUNDS AWARDED TO SPECIAL AWARD RECIPIENTS ARE GIVEN AS STIPENDS OR PRIZES, NOT FOR SPECIFIC RESEARCH PROJECTS THAT ARE SUBJECT TO REPORTING. DUE TO THE TYPE OF AWARD THERE IS NO FOLLOW UP ON THE USE OF THE FUNDS. THE GIANNI BONADONNA BREAST CANCER AWARD RECIPIENTS ARE REQUIRED TO NOTIFY GRANT SUPPORT STAFF IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET SUCH TIME SCHEDULES AS MAY HAVE BEEN PROPOSED. GRANTEES ARE REQUIRED TO NOTIFY THE GRANT SUPPORT STAFF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. THE GRANT SUPPORT STAFF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS FOLLOWING THE END OF THE GRANT BUDGET PERIOD. THE GRANT SUPPORT STAFF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. THE GRANT SUPPORT STAFF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS FOLLOWING EXPIRATION OF THE GRANT. THE GRANT SUPPORT STAFF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED. GRANTS ARE ADMINISTRATIVELY CLOSED BY THE GRANT SUPPORT STAFF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER THE GRANT SUPPORT STAFF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. THE GRANT SUPPORT STAFF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET. ADVANCED CLINICAL RESEARCH AWARD (ACRA) IS DESIGNED FOR CLINICAL ONCOLOGY RESEARCHERS INVOLVED IN INVESTIGATIVE WORK FOR 5-10 YEARS AND INTENDED TO SUPPORT ORIGINAL RESEARCH NOT CURRENTLY FUNDED. TOTAL GRANT: $450,000 OVER THREE YEARS. TRANSLATIONAL RESEARCH PROFESSORSHIP AWARD (TRP) IS INTENDED TO SUPPORT QUALIFIED RESEARCHERS WHO ARE DEDICATED TO BRINGING ADVANCES IN BASIC SCIENCES INTO THE CLINICAL ARENA AND TO MENTORING OTHER TRANSLATIONAL RESEARCHERS. TOTAL GRANT: $300,000 OVER THREE YEARS. CAREER DEVELOPMENT AWARD (CDA) PROVIDES FUNDING TO CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENT TO ESTABLISH AN INDEPENDENT CLINICAL CANCER RESEARCH PROGRAM. TOTAL GRANT: $200,000 OVER THREE YEARS. GIANNI BONADONNA BREAST CANCER AWARD AND FELLOWSHIP RECOGNIZES AN ACTIVE CLINICAL OR TRANSLATIONAL RESEARCHER WITH A DISTINGUISHED RECORD OF ACCOMPLISHMENTS IN ADVANCING THE FIELD OF BREAST CANCER. THE RECIPIENT RECEIVES A $10,000 AWARD AND DELIVERS A LECTURE DURING THE BREAST CANCER SYMPOSIUM. THE AWARD IS ACCOMPANIED BY A ONE-YEAR $50,000 FELLOWSHIP AWARD TO AN EARLY-CAREER BREAST CANCER RESEARCHER AT THE AWARD RECIPIENT'S AFFILIATED INSTITUTION. THE FELLOWSHIP AWARD WILL FUND AN INVESTIGATOR WHOSE BREAST CANCER RESEARCH HAS A PATIENT-ORIENTED FOCUS, INCLUDING CLINICAL TRIALS OR TRANSLATIONAL RESEARCH INVOLVING HUMAN PARTICIPANTS. YOUNG INVESTIGATOR AWARD (YIA) PROVIDES FUNDING TO PROMISING INVESTIATORS TO ENCOURAGE AND PROMOTE QUALITY RESEARCH IN CLINICAL ONCOLOGY. THE PURPOSE OF THIS AWARD IS TO FUND PHYSICIANS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. TOTAL GRANT: $50,000 OVER ONE YEAR. IMPROVING CANCER CARE GRANT (ICCG), FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES EXTRAMURAL RESEARCH FUNDING TO ADDRESS IMPORTANT ISSUES REGARDING ACCESS TO HEALTHCARE, QUALITY OF CARE, AND DELIVERY OF CARE, WITH GENERAL APPLICABILITY TO BREAST CANCER. THE GOAL OF THIS PROGRAM IS TO ENCOURAGE MULTI-DISCIPLINARY RESEARCH THAT WILL HAVE A MAJOR IMPACT ON CANCER CARE, WITH GENERAL APPLICABILITY IN THE BREAST CANCER ARENA. TOTAL GRANT: $1,350,000 OVER THREE YEARS. COMMUNITY ONCOLOGY RESEARCH GRANT (CORG)IS GIVEN TO COMMUNITY-BASED PRACTICES TO SUPPORT THEIR EFFORTS TO ENHANCE THEIR CLINICAL TRIALS PROGRAM. AREAS OF IMPROVEMENT ARE BASED ON THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY STATEMENT OF MINIMUM STANDARDS AND EXEMPLARY ATTRIBUTES OF CLINICAL TRIAL SITES (JOURNAL OF CLINICAL ONCOLOGY, MAY 20 2008). TOTAL GRANT: $30,000 OVER ONE YEAR. STATE AFFILIATE GRANT PROGRAM (SAGP)- THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY CREATED THE STATE AFFILIATED GRANT PROGRAM IN 2005 TO PROVIDE FINANCIAL SUPPORT TO ITS STATE/REGIONAL AFFILIATES AS THEY SEEK TO ENHANCE THE SCOPE OF THEIR ACTIVITIES. ALL 48 AFFILIATES ARE ELIGIBLE TO APPLY FOR A GRANT. IN 2011, CCF PROVIDED $50,000 TO FIVE STATE SOCIETIES TO ENGAGE IN PROJECTS THAT WILL HAVE AN OVERALL BENEFIT TO THEIR MEMBERS, ASCO MEMBERS, OTHER STATE SOCIETIES AND THE GENERAL ONCOLOGY COMMUNITY. MERIT AWARDS ARE DESIGNED TO FURTHER PROMOTE CLINICAL RESEARCH BY YOUNG SCIENTISTS AND TO PROVIDE FELLOWS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS. A SELECT NUMBER OF CCF MERIT AWARDS ARE GIVEN ANNUALLY TO RECOGNIZE OUTSTANDING ABSTRACTS SUBMITTED FOR CONSIDERATION FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING. THE AWARDS ARE GIVE TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON SELECTED ABSTRACTS, AND THE CRITERIA ARE DESCRIBED IN THE ELIGIBILITY AND AWARD TERMS SECTIONS. CLINICAL TRIALS PARTICIPATION AWARD (CTPA)- INTENDED TO INCREASE AWARENESS AND PARTICIPATION IN CLINICAL TRIALS AMOUNG PHYSICIANS. NOMINATIONS ARE REQUESTED FROM THE ASCO CLINICAL PRACTICE COMMITTEE, COMMUNITY CLINICAL ONCOLOGY PROGRAM, EACH OF THE NCI COOPERATIVE GROUPS, AND VARIOUS COMMUNITY-BASED ONCOLOGY RESEARCH NETWORKS. CCF PROVIDES THE FUNDING FOR THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA). THE IDEA IS PROVIDED TO ONCOLOGISTS IN DEVELOPING COUNTRIES TO LEARN ABOUT ONCOLOGY AT THE ASCO ANNUAL MEETING, AT A CANCER CENTER, AND TO DEVELOP LONG-TERM RELATIONSHIPS TO IMPROVE CANCER CARE IN THEIR COUNTRIES. LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE) PROVIDES EARLY-CAREER ONCOLOGISTS IN DEVELOPING NATIONS THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION. THROUGH A ONE OR TWO YEAR FELLOWSHIP, THE RECIPIENT WILL EARN VALUABLE TRAINING AND EXPERIENCE WITH WHICH THEY CAN AFFECT CHANGE IN CANCER CARE IN THEIR HOME COUNTRY. RECIPIENTS MUST RETURN TO THEIR HOME INSTITUTIONS AFTER COMPLETING THEIR FELLOWSHIP AND ARE EXPECTED TO DISSEMINATE THE KNOWLEDGE THEY HAVE GAINED. ONCOLOGY TRAINEE TRAVEL AWARDS (OTTA) ALLOW FOR THE SUPPORT OF CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS FROM THE UNITED STATES AND CANADA, BY PROVIDING THEM INDIVIDUAL TRAVEL GRANTS TO DEFRAY TRAVEL EXPENSES FOR ATTENDING THE ASCO ANNUAL MEETING. LOAN REPAYMENT PROGRAM- THE ASCO LOAN REPAYMENT PROGRAM (LRP), FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES REPAYMENT OF QUALIFYING EDUCATIONAL DEBT TO ONCOLOGISTS, OR TO ONCOLOGY FELLOWS UPON COMPLETION OF TRAINING, WHO COMMIT TO PRACTICING ONCOLOGY IN A MEDICALLY UNDERSERVED REGION OF THE UNITED STATES. MEDICAL STUDENT ROTATION (MSR)- THE ASCO MEDICAL STUDENT ROTATION, FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES 8- TO 10-WEEK CLINICAL OR CLINICAL RESEARCH ONCOLOGY ROTATIONS FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER.	Explanation

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Severance Payment	0	SeverancePayment
Supplemental Nonqual Retire Plan	0	SupplementalNonqualRetirePlan
Equity Based Comp Arrangement	0	EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org	0	CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs	0	CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org	0	CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs	0	CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments	0	AnyNonFixedPayments
Initial Contract Exception	0	InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (4 entries)

Base Compensation Filing OrgBaseCompensationFilingOrg	Comp Based On Related OrgsCompBasedOnRelatedOrgs	Bonus Filing OrgBonusFilingOrg	Bonus Related OrgsBonusRelatedOrgs	Other Compensation Filing OrgOtherCompensationFilingOrg	Other Compensation Related OrgsOtherCompensationRelatedOrgs	Deferred Comp Filing OrgDeferredCompFilingOrg	Deferred Comp Related OrgsDeferredCompRelatedOrgs	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg	Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs	Total Compensation Filing OrgTotalCompensationFilingOrg	Total Compensation Related OrgsTotalCompensationRelatedOrgs	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg	Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
ALLEN LICHTER MD
0	666323	0	67571	0	15000	0	18375	0	1787	0	769056	0	0
NANCY DALY MS MPH
0	199675	0	10849	0	0	0	11722	0	12209	0	234455	0	0
DINA MICHELS ESQ
0	468167	0	0	0	0	0	18375	0	15692	0	502234	0	0
PAUL AINES CPA
0	282362	0	5000	0	0	0	16442	0	16509	0	320313	0	0

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (11 entries)

Return ReferenceReturnReference	ExplanationExplanation	IdentifierIdentifier
FORM 990, PART VI, SECTION A, LINE 1	AS OF DECEMBER 31, 2011, THE BOARD OF DIRECTORS OF CCF INCLUDED TWELVE (12) DIRECTORS WITH VOTING RIGHTS AND TWO (2) DIRECTORS WITHOUT VOTING RIGHTS. ELEVEN (11) DIRECTORS WITH VOTING RIGHTS WERE APPOINTED BY THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO) A NON-PROFIT, 501(C)(3) TAX EXEMPT ORGANIZATION, A RELATED ORGANIZATION. THERE WERE THREE EX OFFICIO DIRECTORS: THE CHIEF EXECUTIVE OFFICER (WITH VOTING RIGHTS), THE ASCO PRESIDENT (WITHOUT VOTING RIGHTS) AND THE EXECUTIVE DIRECTOR (WITHOUT VOTING RIGHTS). ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS HAVE THE SAME VOTING RIGHTS. CONSISTENT WITH CCF'S BYLAWS, DURING THE REPORTED TAX YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE IS COMPOSED OF THE CHAIR, CEO, SECRETARY, TREASURER, AND A FIFTH EXECUTIVE COMMITTEE MEMBER ELECTED BY THE DIRECTORS. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF CCF'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY CCF'S BYLAWS, WHICH PROVIDE THAT EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW AND EXCEPTED AS SPECIFIED IN THE BYLAWS, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT DECIDIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH CCF'S BYLAWS.
FORM 990, PART VI, SECTION A, LINE 1	ONE VOTING MEMBER OF CCF'S BOARD OF DIRECTORS DOES NOT MEET THE DEFINITIONAL TEST OF AN INDEPENDENT MEMBER OF CCF'S GOVERNING BODY: ALLEN LICHTER, M.D. IS AN EX-OFFICIO, VOTING MEMBER OF CCF'S BOARD OF DIRECTORS WHO SERVES AS THE CEO OF CCF AND THE CEO OF ASCO (A RELATED ORGANIZATION OF CCF). HE IS AN EMPLOYEE OF ASCO AND RECEIVED COMPENSATION FROM ASCO.
FORM 990, PART VI, SECTION A, LINE 4	DURING THE REPORTED TAX YEAR, CCF AMENDED ITS ARTICLES OF INCORPORATION TO ADD THE ASCO PRESIDENT AS AN EX-OFFICIO, NON-VOTING MEMBER OF ITS BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION A, LINE 7A	CCF DOES NOT HAVE MEMBERS. DIRECTORS OF CCF ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO.
FORM 990, PART VI, SECTION A, LINE 7B	THE BOARD OF DIRECTORS OF CCF MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CCF, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE.
FORM 990, PART VI, SECTION B, LINE 11	AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE CCF FINANCE COMMITTEE AND WAS DISCUSSED AT A MEETING OF THE FINANCE COMMITTEE BEFORE IT WAS FILED. AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT WAS FILED. THE CCF FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE EXECUTIVE DIRECTOR, THE CHIEF EXECUTIVE OFFICER, AND THE GENERAL COUNSEL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12C	CCF MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL CCF STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). UNDER CCF'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. CCF'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, WHEN CCF IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY "INTERESTED PERSON" (I.E., A CCF DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	THE FOLLOWING EMPLOYEES OF ASCO SERVE AS OFFICERS OF CCF. INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION ARE DESCRIBED IN THE IRS FORM 990 OF ASCO: CEO OF CCF (ALSO SERVES AS CEO OF ASCO) EXECUTIVE DIRECTOR OF CCF CFO OF CCF (ALSO SERVES AS CFO OF ASCO) GENERAL COUNSEL OF CCF (ALSO SERVES AS VP/GENERAL COUNSEL OF ASCO) CCF STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CCF. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO.
FORM 990, PART VI, SECTION C, LINE 19	CCF'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. CCF'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CCF'S WEBSITE. THE ANNUAL REPORT OF CCF IS POSTED ON CCF'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST.
FORM 990, PART XI, LINE 5:	NET UNREALIZED LOSSES ON INVESTMENTS: -1,286,288.	CHANGES IN NET ASSETS OR FUND BALANCES:
FORM 990, PART XII, LINE 2C	THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII

Name Of Disregarded Entity NameOfDisregardedEntity

Field	Value	IRS element (for citing)
Business Name Line1	AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC	BusinessNameLine1

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
EIN	136180380	EIN
Primary Activities	SUPPORTS CANCER RESEARCH, EDUCATION AND QUALITY IMPROVEMENT PROGRAMS	PrimaryActivities
Legal Domicile State	NY	LegalDomicileState
Exempt Code Section	501(C)(3)	ExemptCodeSection
Public Charity Status	LINE 9	PublicCharityStatus
Direct Controlling Entity NA	N/A	DirectControllingEntityNA
Controlled Org	0	ControlledOrg

Field	Value	IRS element (for citing)
Receipt Of Int Ann Rents Royalties	0	ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org	1	GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org	1	GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org	1	LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org	0	LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org	0	SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org	0	PurchaseOfAssetsFromOtherOrg
Exchange Of Assets	0	ExchangeOfAssets
Rental Of Facilities To Other Orgs	0	RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs	1	RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs	1	PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs	0	PerformOfServicesByOtherOrgs
Sharing Of Facilities	0	SharingOfFacilities
Sharing Of Paid Employees	1	SharingOfPaidEmployees
Reimbursement Paid To Other Org	1	ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org	1	ReimbursementPaidByOtherOrg
Other Transfer To Other Org	0	OtherTransferToOtherOrg
Other Transfer From Other Org	0	OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (8 entries)

Transaction TypeTransactionType	Amount InvolvedAmountInvolved
AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)
C	871450
ASCO
B	7731584
ASCO
D	64000000
ASCO
K	4676846
ASCO
N	2560538
ASCO
J	231180
ASCO
O	5425123
ASCO
P	2327368